Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Journal of Clinical Microbiology|April 9, 2005
Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearanceHe-Jun Yuan, Man-Fung Yuen, Danny Ka-Ho Wong, et al.Journal of Clinical Microbiology|August 7, 2004
Real-time PCR assay using molecular beacon for quantitation of hepatitis B virus DNASimon Siu-Man Sum, Danny Ka-Ho Wong, Man-Fung Yuen, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2003
Role of hepatitis B virus genotypes in chronic hepatitis B exacerbationMan-Fung Yuen, Erwin Sablon, Danny Ka-Ho Wong, et al.Journal of Clinical Microbiology|September 15, 2004
Long-term follow-up study of Chinese patients with YMDD mutations: significance of hepatitis B virus genotypes and characteristics of biochemical flaresMan-Fung Yuen, He-Jun Yuan, Erwin Sablon, et al.Hepatology (Baltimore, Md.)|October 12, 2011
Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levelsDoan Y Dao, Linda S Hynan, He-Jun Yuan, et al.Journal of Hepatology|July 13, 2004
Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong KongMan-Fung Yuen, Erwin Sablon, Yasuhito Tanaka, et al.Hepatology (Baltimore, Md.)|February 26, 2003
Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinomaMan-Fung Yuen, Erwin Sablon, He-Jun Yuan, et al.The Journal of Infectious Diseases|October 29, 2002
Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virusMan-Fung Yuen, Erwin Sablon, He-Jun Yuan, et al.In Silico Biology|December 4, 2012
Coordinated evolution among hepatitis C virus genomic sites is coupled to host factors and resistance to interferonJames Lara, John E Tavis, Maureen J Donlin, et al.The Journal of Infectious Diseases|August 14, 2009
Pegylated interferon and ribavirin promote early evolution of nonstructural 5A protein in individuals with hepatitis C who demonstrate a response to treatmentMamta K Jain, He-Jun Yuan, Beverley Adams-Huet, et al.Pageof 3